Background: To exploit a unique Swiss developed formulation developing, selling, marketing and distributing a range of health supplements.

IPR jointly owed with Swiss partner.

Two clinically proven products already available in major healthcare retailers and selected multiples aimed at alleviating irritable bowel syndrome and improving immunity from colds, flu and other ailments.

Funded to date by research grants and shareholders.

Approximately £1m of equity investment is sought to accelerate PR and marketing and the development of an internet sales proposition.

Ref: NO10 120